Saturday, March 07, 2020 7:26:10 AM
Northwest Biotherapeutics (NW Bio) along with our partner, Advent Bioservices, is building one of the premier advanced manufacturing facilities in the world, in the Vision Centre on the former Spicers site. This facility will produce personalised immune cell therapies for cancer and other diseases, as well as regenerative medicine cell therapies. The development of the Vision Centre also includes large training facilities to provide specialised job training for this advanced manufacturing.
We hope that our presence in Cambridge will contribute to the local, regional and national economy and that our innovative technology can change the lives of cancer patients in the UK.
The Vision Centre
The Vision Centre in Sawston is fully operational and is currently being fitted out with three ‘cleanroom’ suites, to be used by NW Bio as well as by other organisations that work in advanced cell manufacturing. Once complete, the Vision Centre will play a crucial role in allowing life-saving treatments to reach patients across the rest of Europe.
Land North of Mill Lane
Northwest Biotherapeutics acquired a site to the east of our existing Vision Centre in Sawston, with one possibility being to develop this for housing, some of which could be utilised by staff at the Vision Centre. Due to the nature of advanced manufacturing, blood and biopsy samples can arrive at any time, meaning we must have staff in close proximity to ensure the safe delivery, storage and processing of sensitive materials.
We are promoting the site through the Greater Cambridge Local Plan process and will be consulting with the community. Our aspiration for the site is that it will enhance our offering at the Vision Centre and support the services and other commercial and public facilities already in Sawston.
Our vision for the site at Sawston is one of partnership and growth with the community in and around the village, with employment opportunities at the Vision Centre being an importantpart of the Sawston local economy going forward, just as Spicers was in the past.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
FEATURED Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • Jun 14, 2024 2:07 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM